期刊文献+

胃癌微环境Treg发挥免疫抑制作用机制的初步研究 被引量:3

Mechanism of the immune suppression mediated by regulatory T cells in the microenvironment of gastric cancer
原文传递
导出
摘要 初步探讨胃癌中异常增高的调节性T细胞(Treg)发挥免疫抑制的作用机制。利用多参数流式细胞术检测胃癌肿瘤局部CD4+CD25+Foxp3+Treg的Foxp3和环氧合酶2(COX-2)表达强度。CFSE增殖实验检测不同Foxp3表达强度的Treg对效应性T细胞的增殖抑制作用。在Treg与效应性T细胞共培养体系中加入COX-2抑制剂和前列腺素E2(PGE2)拮抗剂,观察PGE2的分泌水平以及Treg其对效应性T细胞的增殖抑制。结果发现,癌旁淋巴结和肿瘤浸润淋巴细胞(TIL)中Treg的Foxp3表达强度显著高于外周血(P<0.05);高表达Foxp3的Treg具有更强的抑制活性(P<0.05)。胃癌微环境中TregCOX-2表达强度与Foxp3表达强度显著相关(r=0.675,P<0.05)。应用COX抑制剂处理发现能阻断Treg分泌PGE2,COX抑制剂和PGE2拮抗剂均能降低Treg对效应T细胞增殖的抑制作用(P<0.05)。这表明胃癌局部高表达Foxp3的Treg具有较强的免疫抑制活性,COX-2-PGE2-EP2/EP4通路可能为胃癌微环境中Treg抑制效应T细胞增殖的机制之一。 To investigate the mechanism of the immune suppression mediated by the increased numbers of regulatory T cells(Tregs),the expression of Foxp3 and COX-2 in Tregs were analyzed by flow cytometry,and the PGE2 level in the supernatant from the co-culture system was determined by ELISA.The suppression of the effector T-cell response was detected by CFSE assay.In some experiments,COX inhibitors and PGE2 receptor-specific antagonists were added to the co-culture system.It was found that the expression of Foxp3 in tumor-draining lymph nodes and TILs was higher than that in PBMCs(P0.05).Tregs with higher levels of Foxp3 suppressed the proliferation of autologous CD4+CD25-T cells more strongly(P0.05).Elevated expression of Foxp3 in tumor-infiltrating Tregs correlated with the up-regulation of COX-2(r=0.675,P0.05).The Tregs suppression on the effector T-cell response could be reversed by PGE2 and COX-2 inhibitors(P0.05).Our data demonstrate a possible mechanism by which tumor-infiltrating Tregs with increased Foxp3 expression can mediate immune suppression via COX-2/PGE2 production in the gastric cancer microenvironment.
出处 《现代免疫学》 CAS CSCD 北大核心 2010年第5期403-407,共5页 Current Immunology
基金 上海市自然科学基金资助项目(01ZR1420000)
关键词 TREG 胃癌 FOXP3 免疫抑制 gastric cancer regulatory T cells Foxp3 immune suppression
  • 相关文献

参考文献11

  • 1袁向亮,沈定丰,卢剑,董平,王剑,李美星,沈立松.CD127用于特异性识别调节性T淋巴细胞的方法建立及临床应用评价[J].中华检验医学杂志,2008,31(5):499-503. 被引量:11
  • 2王剑,袁向亮,李美星,薛剑,张通通,沈立松.CD4^+CD25^+CD127^lo2-细胞体外抑制效应T淋巴细胞增殖的影响[J].中华检验医学杂志,2009,32(3):340-343. 被引量:6
  • 3Viguier M, Lemaitre F, Verola O, et al. Foxp3 expressing CD4^+ CD25high regulatory T cells are over represented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells [J].J Immunol, 2004, 173: 1444-1453.
  • 4Sasada T, Kimura M, Yoshida Y, et al. CD4+CD25+reg ulatory T cells in patients with gastrointestinal malignancies Possible involvement of regulatory T cells in disease progression[J]. Cancer, 2003, 98: 1089-1099.
  • 5Kono KH, Takahashi A. CD4^+ CD25 high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers[J].Cancer Immunol Immunother, 2006, 55: 1064-1071.
  • 6Shen LS, Wang J, ShenDF, etal. CD4^+CD25^+CD127^low/- regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression [J]. Clin Immunol, 2009,131:109-118.
  • 7李卫鹏,王福庆.CD4^+CD25^+ Treg的免疫调节作用机制以及临床研究进展[J].现代免疫学,2006,26(2):164-167. 被引量:18
  • 8Baratelli F, Lin Y, Zhu L, et al. Prostaglandin E2 induces foxp3 gene expression and T regulatory cell function in human CD4^+ Tcells [J]. J Immunol, 2005,175:1483-1490.
  • 9Yaqub S, Henjum K, Mahic M, etal. Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a cox-2 dependent manner[J]. Cancer Immunol Immunother, 2008,57:813-821.
  • 10Mahic M, Yaqub S, Johansson CC, et al. Foxp3^+CD4^+ CD25^+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effeetor T cells by a prostaglandin e2-dependent mechanism[J].J Immunol, 2006,177:246-254.

二级参考文献40

  • 1Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains ( CD25 ). Breakdown of a single mechanism of selftolerance causes various autoimmune diseases. J Immunol, 1995, 155:1151-1164.
  • 2Wolf AM, Wolf D, Steurer M, et al. Increase in regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res, 2003,9:606-612.
  • 3Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med, 2004,10:942-949.
  • 4Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299 : 1057-1061.
  • 5Marson A, Kretschmer K, Frampton GM, et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature, 2007,445:931-935.
  • 6Williams LM, Rudensky AY. Maintenance of the Foxp3- dependent developmental program in mature regulatory T cells requires continued expression d Foxp3. Nat Immunol ,2007 ,8 :277-284.
  • 7Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + Treg ceils. J Exp Med, 2006,203:1701-1711.
  • 8Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med,2006,203:16933-1700.
  • 9yon Herrath MG, Harrison LC. Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol, 2003,3:223-232.
  • 10Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains ( CD25 ). Breakdown of a single mechanism of self- tolerance causes various autoimmune diseases. J Immunol, 1995, 155 : 1151-1164.

共引文献32

同被引文献41

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部